From DCAT Value Chain Insights (VCI)
Eli Lilly and Company appointed Darren J. Carroll to senior vice president of corporate business development effective January 1, 2015. He has been the vice president of corporate business development since 2010.
During his 18-year career at Lilly, Mr. Carroll has helped to lead and/or created new business models for the company, including e-Lilly, InnoCentive, Lilly Ventures, and Lilly Asia Ventures. He was the driver behind the company's Capital Funds Portfolio strategy with several venture capital fund managers, which has thus far led to the creation of 11 new companies, including Artaeus, which Lilly acquired in January 2014, which is focused on developing novel molecules to clinical proof of concept. In his new role, Mr. Carroll will be responsible for all strategic corporate transactions. including mergers and acquisitions, joint ventures, business collaborations, private equity investments, and out-partnering. He will report to Derica Rice, Lilly's executive vice president of global services and chief financial officer.
Source: Eli Lilly
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription